Suppression of NRF2-ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells. [electronic resource]
- Toxicology and applied pharmacology Feb 2016
- 1-7 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1096-0333
10.1016/j.taap.2015.12.008 doi
3T3 Cells Animals Antineoplastic Agents--therapeutic use Antioxidant Response Elements--drug effects Cell Survival--drug effects Dose-Response Relationship, Drug Ethionamide--therapeutic use Hep G2 Cells Humans Isoniazid--therapeutic use Leukemia, Monocytic, Acute--drug therapy Mice NF-E2-Related Factor 2--antagonists & inhibitors U937 Cells